与优化心力衰竭药物治疗相关的不良药物事件 衰弱的老年人中的药物治疗:一种定性研究
Mai H Duong1,2, Danijela Gnjidic3, Andrew J McLachlan3
1Laboratory of Ageing and Pharmacology, Kolling Institute, Northern Sydney Local Health District and The University of Sydney, Sydney, New South Wales, Australia.
CJC open
|November 3, 2025
概括
患有心力衰竭 (HF) 和虚弱的老年人经历了常见的不良药物事件 (ADEs). 消费者和医疗保健专业人员 (HCP) 的观点强调需要更好的药物管理和协调护理来改善福祉.
科学领域:
- 老年学是指老年学的学科.
- 药理学 药理学是指药理学的学科.
- 质量健康研究 质量健康研究
背景情况:
- 药物不良事件 (ADEs) 在心力衰竭 (HF) 和虚弱的老年人中很常见.
- 在这个人群中优化HF药物治疗仍然具有挑战性.
- 了解患者和提供者对ADE和药物戒断不良影响 (ADWE) 的看法至关重要.
研究的目的:
- 探索消费者和医疗保健专业人员 (HCP) 对HF药物治疗中的ADEs和ADWEs的观点.
- 确定一个概念模型的关键领域,为药物管理提供信息.
- 提高患有HF的脆弱老年人的生活质量.
主要方法:
- 使用半结构面试和焦点小组进行定性研究.
- 在澳大利亚和新西兰进行有目的和雪球采样.
- 一般的诱导分析,以确定主题,并开发一个概念模型.
主要成果:
- 招募了32名参与者 (消费者,心脏病专家,医生,护士,药剂师).
- 关键主题包括个人因素,药物管理和医疗保健准入.
- 消费者希望获得生活质量的支持;由于感知到的好处,医疗保健人员犹不决.
结论:
- 在脆弱的老年人中对HF药物治疗的独特观点突出了治疗,ADEs和ADWEs之间的相互作用.
- 需要改善多学科团队协调和患者获得服务的机会.
- 需要进一步的研究来完善概念模型.
相关概念视频
Drug Dosing: Geriatric Patients
217
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
217
Pharmacodynamics in Geriatric Patients: Effects of Age
182
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
182
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
229
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
229
Heart Failure V: Medical Management
208
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
208
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
218
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
218
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
224
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
224


